Efficacy and safety of dose escalation in male patients with overactive bladder showing poor efficacy after low-dose antimuscarinic treatment: A retrospective multicenter study.
Myungsun ShimJong Keun KimWoo Jin BangYong Seong LeeSung Tae ChoJin Seon ChoKwan Joong JooJae Seog HyunByung Hoon KimJong Bok LeeYoung Jin SeoCheol Young OhPublished in: Investigative and clinical urology (2020)
Standard dose antimuscarinic treatment using solifenacin (5 mg) may be a safe and effective treatment for patients with OAB symptoms refractory to low-dose antimuscarinic treatment.
Keyphrases